EU Guidance Update Explains QP Declarations For GMP Compliance
Executive Summary
Updated EU guidance has been issued on the qualified person (QP) declarations that companies need to provide in order to demonstrate compliance with good manufacturing practice requirements for active substances. The European QP Association believes the real worth of the updated guidance will depend on how tasks are assigned within individual companies.
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.